The global Oxytocic Pharmaceuticals Market was valued at USD 114.57 million in 2023 and is projected to reach USD 210.49 million by 2031, growing at a compound annual growth rate (CAGR) of 7.9% over the forecast period from 2024 to 2031. The rising demand for maternal health products and ongoing advancements in oxytocic drug formulations are key factors...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian